CYPROHEPTADINE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- CYPROHEPTADINE
- Generic name
- CYPROHEPTADINE HYDROCHLORIDE
- Manufacturer
- Chartwell RX, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 37fe7264-4d45-4d6c-ac13-40fcd1d82351
- SPL ID
- 06fd9a7b-3b04-6e0c-e063-6394a90aba46
- Version
- 3
- Effective date
- 2023-10-05
- Source export date
- 2026-09-28
- Source partition
- 3
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:17:53
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 203191 | derived:openfda.application_number |
| application number | ANDA203191 | openfda.application_number | |
| brand name | CYPROHEPTADINE | openfda.brand_name | |
| generic name | CYPROHEPTADINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | Chartwell RX, LLC | openfda.manufacturer_name | |
| ndc | package | 62135-949-47 | openfda.package_ndc |
| ndc | package | 62135-949-94 | openfda.package_ndc |
| ndc | product | 62135-949 | openfda.product_ndc |
| ndc11 | package | 62135094994 | derived:openfda.package_ndc |
| ndc11 | package | 62135094947 | derived:openfda.package_ndc |
| rxcui | 866021 | openfda.rxcui | |
| spl id | 06fd9a7b-3b04-6e0c-e063-6394a90aba46 | id | |
| spl set id | 37fe7264-4d45-4d6c-ac13-40fcd1d82351 | set_id | |
| unii | NJ82J0F8QC | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Children: Overdosage of antihistamines, particularly in infants and children, may produce hallucinations, central nervous system depression, convulsions and death. Antihistamines may diminish mental alertness; conversely, particularly in the young child, they may occasionally produce excitation. CNS Depressants: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents. Activities Requiring Mental Alertness: Patients should be warned about engaging in activities requiring mental alertness and motor coordination, such as driving a car or operating machinery. Antihistamines are more likely to cause dizziness, sedation and hypotension in elderly patients.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Adverse reactions which have been reported with the use of antihistamines are as follows: Central Nervous System: Sedation and sleepiness (often transient), dizziness, disturbed coordination, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, paresthesias, neuritis, convulsions, euphoria, hallucinations, hysteria, faintness. Integumentary: Allergic manifestation of rash and edema, excessive perspiration, urticaria, photosensitivity. Special Senses: Acute labyrinthitis, blurred vision, diplopia, vertigo, tinnitus. Cardiovascular: Hypotension, palpitation, tachycardia, extrasystoles, anaphylactic shock. Hematologic: Hemolytic anemia, leukopenia, agranulocytosis, thrombocytopenia. Digestive System: Dryness of mouth, epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation, jaundice. Genitourinary: Urinary frequency, difficult urination, urinary retention, early menses. Respiratory: Dryness of nose and throat, thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness. Miscellaneous: Fatigue, chills, headache, increased appetite/weight gain.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.